Stefan E G Burdach1,2, Mike-Andrew Westhoff3, Maximilian Felix Steinhauser4, Klaus-Michael Debatin3. 1. Department of Pediatrics and Children's Cancer Research Center (CCRC), Technische Universität München, Koelner Platz 1, 80804, Munich, Germany. stefan.burdach@tum.de. 2. CCC München-Comprehensive Cancer Center and German Translational Cancer Research Consortium (DKTK), Partner Site Munich, Munich, Germany. stefan.burdach@tum.de. 3. Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Eythstr. 24, 89075, Ulm, Germany. 4. Department of Pediatrics and Children's Cancer Research Center (CCRC), Technische Universität München, Koelner Platz 1, 80804, Munich, Germany.
Correction to: Mol Cell Pediatr 5, 6 (2018)https://doi.org/10.1186/s40348-018-0084-3Following publication of the original article [1], the author would like to correct the incorrect grant number found in the Funding statement.Incorrect Funding statement:“This work was supported by grants from Cura Placida Children’s Cancer Research Foundation and the Wilhelm-Sander Stiftung (2009.901.3). It is part of the Prospective Validation of Biomarkers in Ewing Sarcoma for Personalised Translational Medicine (PROVABES; 01KT1311), Funding Program of the Federal Ministry of Education and Research (BMBF), Germany.”Correct Funding statement:“This work was supported by grants from Cura Placida Children’s Cancer Research Foundation and the Wilhelm Sander-Stiftung (2015.028.1). It is part of the Prospective Validation of Biomarkers in Ewing Sarcoma for Personalised Translational Medicine (PROVABES; 01KT1311), Funding Program of the Federal Ministry of Education and Research (BMBF), Germany.The original article has been corrected.